Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?

Figure 5

Selected representative images of immunofluorescence assays for stemness and differentiation markers. Immunofluorescence assays were performed on untreated (Ctrl) and 10 μM Pio-treated GSCs for 72 hs. Each specific maker is in green; phalloidin is in blue and propidium iodide in red.